Dose Escalation Study of Tolerability and Pharmacokinetics of PEDylated Recombinant Human Endostatin(M2ES)in the Treatment of Advanced Solid Tumor
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Endostatin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 15 Feb 2012 Actual patients number is 20 as reported by ClinicalTrials.gov.
- 15 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Feb 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.